Corvus Pharmaceuticals, Inc. — Director's Dealing 2024

May 7, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Corvus Pharmaceuticals, Inc. (CRVS)
CIK: 0001626971
Period of Report: 2024-05-06

Reporting Person: MILLER RICHARD A MD (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-06	Common Stock	P	577634	$1.7312	Acquired	577634	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-05-06	Warrant (Right to Buy)	$3.5	P	559073	Acquired	2025-06-30	Common Stock (559073)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1490119	Indirect

Footnotes

F1: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.

F2: Issued at no additional consideration to the Reporting Person in connection with their subscription for shares of the Issuer's Common Stock at a price of $1.7312.